BIZ NEWS: Biogen to buy experimental Alzheimer's, Parkinson's treatment from Pfizer for $75M plus incentives - BUSINESS DAILY

Hot

Post Top Ad

Your Ad Spot

Monday, 13 January 2020

BIZ NEWS: Biogen to buy experimental Alzheimer's, Parkinson's treatment from Pfizer for $75M plus incentives


Biogen to buy experimental Alzheimer's, Parkinson's treatment from Pfizer for $75M plus incentives



“This asset is highly complementary to our existing pipeline of potential disease-modifying therapies in Alzheimer’s and Parkinson’s diseases,” Biogen Chief Medical Officer Alfred Sandrock Jr. said in a statement.

via FOX BUSINESS NEWS https://ift.tt/2tZyICr

No comments:

Post a Comment

Post Top Ad